Skip to main content

Atrial Fibrillation: Non Surgical Management

  • 1309 Accesses

Abstract

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in clinical practice. The prevalence of AF increases with age. Indeed, there is one in four chance for both men and women aged 40 and above to develop AF during their life.1 With the increase in aging population, AF has become a major condition that requires extra resources in its management as well as the complications associated with it.

Keywords

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham heart study. Circulation. 2004;110:1042-1046.

    Article  PubMed  Google Scholar 

  2. Fox CS, Parise H, D’Agostino RB Sr, et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA. 2004;291:2851-2855.

    Article  CAS  PubMed  Google Scholar 

  3. Waldo AL. Mechanism of atrial fibrillation. J Cardiovasc Electrophysiol. 2003;14(12 Suppl): S267-S274.

    Article  PubMed  Google Scholar 

  4. Saffitz JE. Connexins, conduction, and atrial fibrillation. N Engl J Med. 2006;354(25):2712-2714.

    Article  CAS  PubMed  Google Scholar 

  5. Watson T, Shantsila E, Lip GYH. Mechanisms of thrombogenesis in atrial fibrillation. Virchow’s triad revisited. Lancet 2008;372.

    Google Scholar 

  6. National Collaborating Centre for Chronic Conditions. Atrial Fibrillation: national clinical guideline for management in primary and secondary care. London: Royal College of Physicians, 2006 (http://rcplondon.ac.uk/pubs/books/af/index.asp).

  7. Lip GY, Tse HF. Management of atrial fibrillation. Lancet. 2007;370:604-618.

    Article  PubMed  Google Scholar 

  8. Van Gelder IC, Wyse DG, Chandler ML, Cooper HA, Olshansky B, Hagens VE, Crijns HJ, RACE and AFFIRM. Does intensity of rate-control influence outcome in artial fribrillation. An analysis of pooled date from the RACE and AFFIRM studies. Europace. 2006; 8:935–942.

    Google Scholar 

  9. Li Saw Hee FL, Lip GYH. Digoxin revisited. QJM. 1998; 91:259-264.

    Article  CAS  PubMed  Google Scholar 

  10. Naccarelli GV, Wolbrette DL, Khan M, et al. Old and new antiarrythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Am J Cardiol. 2003;91:15-26D.

    Article  Google Scholar 

  11. Singh BN, Singh SN, Reda DJ, Tang XC, Lopez B, Harris CL, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis HD Jr, Raisch DW, Ezekowitz MD, Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med. 2005;352:1861-1872.

    Google Scholar 

  12. Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):546S-592S.

    Article  CAS  PubMed  Google Scholar 

  13. Alboni P, Botto GL, Baldi N, et al. Outpatient treatment of recent-onset atrial fibrillation with the “pill-in-the-pocket” approach. N Engl J Med. 2004;351:2384-2391.

    Article  CAS  PubMed  Google Scholar 

  14. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation – pharmacological intervention in atrial fibrillation (PIAF): a randomised trial. Lancet. 2000; 356:1789-1794.

    Article  CAS  PubMed  Google Scholar 

  15. Testa L, Biondi-Zoccai GG, Dello Russo A, Bellocci F, Andreotti F, Crea F. Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis. Eur Heart J. 2005;26(19):2000-2006.

    Article  PubMed  Google Scholar 

  16. Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med. 2008;358(25):2667-2677.

    Article  CAS  PubMed  Google Scholar 

  17. Rawles JM. What is meant by a ‘controlled’ ventricular rate in atrial fibrillation? Br Heart J. 1990;63:157-161.

    Article  CAS  PubMed  Google Scholar 

  18. Khand AU, Rankin AC, Martin W, Taylor J, Gemmell I, Cleland JG. Carverdilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? J Am Coll Cardiol. 2003;42:1944-1951.

    Article  CAS  PubMed  Google Scholar 

  19. Segal JB, McNamara RL, Miller MR, et al. The evidence regarding the drugs used for ventricular rate control. J Fam Pract. 2000;49:47-59.

    CAS  PubMed  Google Scholar 

  20. Farshi R, Kistner D, Sarma JS, Longmate JA, Singh BN. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open label study of five drug regimens. J Am Coll Cardiol. 1999; 33:304-310.

    Article  CAS  PubMed  Google Scholar 

  21. Roth A, Harrison E, Mitani G, Cohen J, Rahimtoola SH, Elkayam U. Efficacy and safety of medium-and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation. Circulation. 1986;73:316-324.

    CAS  PubMed  Google Scholar 

  22. Saksena S, Madan N. Hybrid therapy of atrial fibrillation: algorithms and outcome. J Interv Card Electriohysiol. 2003;9:235-247.

    Article  Google Scholar 

  23. Oral H, Knight BP, Tada H, et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation. 2002;105:1077-1081.

    Article  PubMed  Google Scholar 

  24. Marrouche NF, Martin DO, Wazni O, et al. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outome and complications. Circulation. 2003; 107: 2710-2716.

    Article  PubMed  Google Scholar 

  25. Oral H, Chugh A, Good E, et al. A tailored approach to catheter ablation of paroxysmal atrial fibrillation. Circulation. 2006;113:1824-1831.

    Article  PubMed  Google Scholar 

  26. Healey JS, Toff WD, Lamas GA, et al. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation. 2006;114:11-17.

    Article  PubMed  Google Scholar 

  27. Friedman PA, Dijkman B, Warman EN, et al. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation. 2001;104:1023-1028.

    Article  CAS  PubMed  Google Scholar 

  28. Lip GY, Boss CJ. Antithrombotic treatment in atrial fibrillation. Heart. 2006;92:155-161.

    Article  CAS  PubMed  Google Scholar 

  29. Hughes M, Lip GY, Guideline Development Group, National Clinical Guideline for Management of Atrial Fibrillation in Primary and Secondary Care, National Institute for Health and Clinical Excellence. Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data. Thromb Haemost. 2008;99(2):295-304.

    CAS  PubMed  Google Scholar 

  30. Gage BF, van Walraven C, Pearce L, et al. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation. 2004;110: 2287-2292.

    Article  CAS  PubMed  Google Scholar 

  31. Hughes M, Lip GY, on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care. Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review. QJM. 2007;100:599-607.

    Article  CAS  PubMed  Google Scholar 

  32. Healey JS, Baranchuk A, Crystal E, et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol. 2005;45:1832-1839.

    Article  CAS  PubMed  Google Scholar 

  33. Boos CJ, Lip GY. Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials. J Hum Hypertens. 2005;19:855-859.

    Article  CAS  PubMed  Google Scholar 

  34. Boos CJ, Anderson R, Lip GYH. Is atrial fibrillation an inflammatory disorder? Eur Heart J. 2006;27:136-149.

    Article  PubMed  Google Scholar 

  35. Stiles S. Dronedarone safety, efficacy standings bolstered in huge atrial-fibrillation trial. theheart.org. [HeartWire > Electrophysiology]; May 19, 2008. Available at: http://www.theheart.org/article/867591.do. Accessed June 24, 2008.

  36. Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest, 2010; 137, 263-272.

    Article  PubMed  Google Scholar 

  37. Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey. Chest 2010;Mar 18.[Epub]. doi: 10.1378/chest.10-134.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gregory Y. H. Lip .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag London Limited

About this chapter

Cite this chapter

Khoo, C.W., Lip, G.Y.H. (2010). Atrial Fibrillation: Non Surgical Management. In: Bonser, R., Pagano, D., Haverich, A. (eds) Mitral Valve Surgery. Springer, London. https://doi.org/10.1007/978-1-84996-426-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-84996-426-5_13

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84996-425-8

  • Online ISBN: 978-1-84996-426-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics